Effects of bortezomib on intracellular antioxidant and apoptosis in HepG2cells
PeerJ · 2025
DOI: 10.7717/peerj.19235 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Grażyna Świderska-Kołacz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biology, Jan Kochanowski University, Kielce, Poland. Hauptthemen laut MEDLINE: Bortezomib, Apoptosis, Antioxidants, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minister of Education and Science called “Regional Initiative of Excellence”.
Abstract (Originalsprache)
Bortezomib, as a proteasome inhibitor, is used in clinical trials related to solid cancers. However, its use is not always associated with a good response to treatment. Taking into account the above, we decided to analyze the effect of the time-dependency (24 vs. 48 h) and the dose-dependency of bortezomib (2, 4, 8 and 16 nM) on apoptosis and activities of antioxidant enzymes such as catalase (CAT), superoxide dismutase (SOD), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione transferase (GST), as well as concentrations of reduced glutathione (GSH) and malondialdehyde (MDA) in hepatoblastoma cell line (HepG2) cells. We have shown that increasing concentrations of bortezomib caused (I) a gradual decrease in the levels of GSH; (II) changes in MDA concentrations and antioxidant enzymes activities; (III) increase in apoptosis levels in HepG2 cells. We did not find significant association between antioxidant parameters and number of apoptotic cells. Our study showed that the analyzed parameters (such as: CAT, SOD, GR, GPx, GST, GSH, MDA) changed after bortezomib treatment. It is important to search for new anti-cancer therapies based on next-generation proteasome inhibitors. It is possible that the use of proteins associated with oxidative stress will help enhance the action of these inhibitors and will provide a better treatment effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biology, Jan Kochanowski University, Kielce, Poland.
- Institute of Human Sciences, Academy of Zamość, Zamość, Poland.
- Academic Laboratory of Psychological Tests, Medical University of Lublin, Lublin, Poland.
- Department of Geobotany and Landscape Planning, Nicolaus Copernicus University of Torun, Toruń, Poland.
- Department of Animal Physiology and Neurobiology, Nicolaus Copernicus University of Torun, Toruń, Poland.
Förderung
- Minister of Education and Science called “Regional Initiative of Excellence”
Zitieren
APA
Świderska-Kołacz, G., Madej, M., Zmorzynski, S., Styk, W., Surowiec, I., Witek, B., Wojciechowska, A., Czerwik-Marcinkowska, J., & Nowakowska, A. (2025). Effects of bortezomib on intracellular antioxidant and apoptosis in HepG2cells. PeerJ. https://doi.org/10.7717/peerj.19235
Vancouver
Świderska-Kołacz G, Madej M, Zmorzynski S, Styk W, Surowiec I, Witek B, et al. Effects of bortezomib on intracellular antioxidant and apoptosis in HepG2cells. PeerJ. 2025. doi:10.7717/peerj.19235
BibTeX
@article{widerskaKoacz2025,
author = {Świderska-Kołacz, Grażyna and Madej, Magdalena and Zmorzynski, Szymon and Styk, Wojciech and Surowiec, Iwona and Witek, Bożena and Wojciechowska, Anna and Czerwik-Marcinkowska, Joanna and Nowakowska, Anna},
title = {Effects of bortezomib on intracellular antioxidant and apoptosis in HepG2cells},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.19235}
}
EUVIMED